This HTML5 document contains 31 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n9http://linked.opendata.cz/resource/domain/vavai/subjekt/
n15http://linked.opendata.cz/ontology/domain/vavai/riv/podDruhVysledku/
n4http://linked.opendata.cz/ontology/domain/vavai/
shttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
n5http://linked.opendata.cz/ontology/domain/vavai/riv/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n13http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F00064190%3A_____%2F13%3A%230000739%21RIV14-MZ0-00064190/
n12http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n16http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n17http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n10http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n6http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n14http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F00064190%3A_____%2F13%3A%230000739%21RIV14-MZ0-00064190
rdf:type
n4:Vysledek skos:Concept
dcterms:description
A long-term 5-year study investigating whether tocilizumab (study drug) continues to be safe and effective in patients with moderate to severe rheumatoid arthritis (RA) who have completed participation in one of the tocilizumab short-term core studies A long-term 5-year study investigating whether tocilizumab (study drug) continues to be safe and effective in patients with moderate to severe rheumatoid arthritis (RA) who have completed participation in one of the tocilizumab short-term core studies
dcterms:title
Long-term extension study of safety during treatment with tocilizumab (MRA) in patients completing treatment in MRA core studies. Long-term extension study of safety during treatment with tocilizumab (MRA) in patients completing treatment in MRA core studies.
skos:prefLabel
Long-term extension study of safety during treatment with tocilizumab (MRA) in patients completing treatment in MRA core studies. Long-term extension study of safety during treatment with tocilizumab (MRA) in patients completing treatment in MRA core studies.
skos:notation
RIV/00064190:_____/13:#0000739!RIV14-MZ0-00064190
n4:predkladatel
n9:ico%3A00064190
n5:aktivita
n10:N
n5:aktivity
N
n5:dodaniDat
n14:2014
n5:domaciTvurceVysledku
n11:4101189
n5:druhVysledku
n15:V%2FS
n5:duvernostUdaju
n16:U
n5:entitaPredkladatele
n13:predkladatel
n5:idSjednocenehoVysledku
85389
n5:idVysledku
RIV/00064190:_____/13:#0000739
n5:jazykVysledku
n17:eng
n5:klicovaSlova
rheumatoid arthritis
n5:klicoveSlovo
n12:rheumatoid%20arthritis
n5:kontrolniKodProRIV
[6FE9226F774D]
n5:mistoVydani
Praha
n5:objednatelVyzkumneZpravy
MKS Research, s.r.o.
n5:obor
n6:FP
n5:pocetDomacichTvurcuVysledku
1
n5:pocetTvurcuVysledku
1
n5:rokUplatneniVysledku
n14:2013
n5:tvurceVysledku
Sedláčková, Marie
s:numberOfPages
1